Pregnancy in Patients with Prosthetic Heart Valve.
- Author:
Suk Yeol LEE
1
;
Byung Chul JANG
;
Han Gy PARK
;
Yong Won PARK
;
Myun Sik KANG
;
Sung Nok HONG
;
Bum Koo CHO
;
Pill Hoon HONG
Author Information
1. Division of Cardiovascular Surgery, Yonsei Cardiovascular Center, Yonsei University College of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Heart valve prosthesis;
Pregnancy;
Anticoagulation
- MeSH:
Abortion, Spontaneous;
Abortion, Therapeutic;
Bioprosthesis;
Female;
Fetus;
Hand;
Heart Valve Prosthesis;
Heart Valves*;
Heart*;
Heparin;
Humans;
Pregnancy Trimester, First;
Pregnancy*;
Retrospective Studies;
Stillbirth;
Warfarin
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
1999;32(11):1023-1030
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: This is a retrospective study of 42 pregnancies from 33 women with prosthetic heart valves who were on anticoagulation regimen prior to or during their pregnancy. MATERIAL AND METHOD: Of the 17 women with bioprosthesis, 15 had 21 pregnancies following cessation of the anticoagulation therapy which resulted in the delivery of 20 healthy babies and 1 abortion. Remaining 2 had 3 pregnancies maintained with heparin, resulting in 2 healthy babies and 1 spontaneous abortion. RESULT: Among 16 women with mechanical heart valves, there were 7 pregnancies during which warfarin was used and this was associated with 4 fetal wastages(2 therapeutic abortion, 1 spontaneous abortion and 1 stillbirth with cerebral hemorrhage). However, in pregnancies where heparin was used, there was no fetal wastage. A patient who did not take anticoagulant for the first trimester and took warfarin for the remaining period and a patient who did not take anticoagulant during pregnancy delivered normal babies. There was an other fetal wastage in a patient on anti-platelet therapy for the first trimester and warfarin therapy for the remaining periods. There was 1 minor petechial complication in a heparin administered group. CONCLUSION: The study indicates that woman with bioprosthetic heart valves can go through pregnancy without undue risks or complications. On the other hand, the use of warfarin during pregnancy in women with mechanical heart valves, was shown to be associated with unacceptable high risk for the fetus. However, in the same group of women, judicious use of heparin during pregnancy was accompanied by a much reduced risk. The safety and adequate therapeutic range of heparin usage under such circumstances are subject to further studies.
